Exousia Bio (LMMY) Receivables (2023 - 2024)

Exousia Bio's (LMMY) quarterly Receivables came in at $16689.0 in Q4 2024, up 330.68% year-on-year from $3875.0 in Q4 2023, and up 3.55% quarter-over-quarter from $16117.0 in Q3 2024.

Exousia Bio (LMMY) Receivables (2023 - 2024) Analysis & Trends

Exousia Bio has disclosed Receivables across 2 years of filings, most recently posting $16689.0 for Q4 2024.

  • Receivables for Q4 2024 came in at $16689.0, up 330.68% year-over-year; the trailing twelve-month figure through Nov 2024 was $16689.0 (up 330.68% YoY), and the FY2024 annual result was $11936.0, changed N/A from the prior year.
  • Receivables came in at $16689.0 for Q4 2024 at Exousia Bio, up from $16117.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $16689.0 in Q4 2024 to a low of $3875.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 51Talk Online Education 7.03 Bn 6.99 Bn 22.18 Mn -
2 Laureate Education 5.22 Bn 5.06 Bn -16.39 Mn 175.95 Mn
3 Graham Holdings 5.09 Bn 4.08 Bn 841.00 Mn 578.99 Mn
4 Covista 4.40 Bn 4.40 Bn 276.31 Mn 173.26 Mn
5 Stride 4.17 Bn 3.36 Bn 231.57 Mn 959.30 Mn
6 Grand Canyon Education 3.94 Bn 3.69 Bn 244.77 Mn 117.79 Mn
7 McGraw Hill 2.19 Bn 1.94 Bn 388.89 Mn 386.05 Mn
8 Universal Technical Institute 2.14 Bn 1.97 Bn 103.97 Mn 44.62 Mn
9 Perdoceo Education 2.13 Bn 1.45 Bn 174.68 Mn 46.55 Mn
10 Exousia Bio - - -62,108.00 -

Historic Data

Download Data
DateValue
Nov 30, 2024 16,689.00
Aug 31, 2024 16,117.00
May 31, 2024 11,936.00
Feb 29, 2024 7,750.00
Nov 30, 2023 3,875.00